Biotech | October 07, 2025
Lonza expands cell and gene therapy portfolio
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
These medicines are essential in preventing RhD immunisation during pregnancy
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
This is the fourth authorized indication in Europe for Reblozyl, a first-in-class treatment for patients with disease-related anemia
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Subscribe To Our Newsletter & Stay Updated
